GOTHENBURG, SE / ACCESS Newswire / August 22, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced ...

STOCKHOLM, SE / ACCESS Newswire / August 22, 2025 / Vicore Pharma Holding AB (STO: VICO) ("Vicore"), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...

VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure ...

Partnership aims to scale personalized, root-cause care with AI automation while preserving the patient-first approach of functional medicine. IRVING, TEXAS / ACCESS Newswire / August 21, 2025 / After ...

Sustained acoustic medicine provided Lia Winter with a way to recover quickly without the need for invasive surgery to repair a herniated cervical disc. TRUMBULL, CONNECTICUT / ACCESS Newswire / ...

This announcement has been revised to correct Dr. Alonso Martin's background information. MIAMI BEACH, FLORIDA / ACCESS Newswire / August 21, 2025 / BODYWELLE, a modern aesthetic and longevity clinic ...

AUSTIN, TX / ACCESS Newswire / August 21, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum ...

The new advisors will provide guidance and support to Ridge RTC residents while also spreading awareness about the need for high-quality teen behavioral health and substance use treatment MILTON, NH / ...

Bilayered BruxZir® restoration offers results virtually indistinguishable from natural teeth IRVINE, CA / ACCESS Newswire / August 21, 2025 / Glidewell has launched BruxZir® Glass, a bilayered ceramic ...

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of ...

Aiming to Enter Clinical Trials for Residual & Metastatic HCC in 2026 MIAMI, FL and LANSING, MI / ACCESS Newswire / August 21, 2025 / NAYA Therapeutics ("NAYA"), a clinical-stage biopharmaceutical ...

Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a ...